ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
64,149.06
0.40%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. TG Therapeutics Inc (TGTX)

  7. TG Therapeutics Inc (TGTX) 뉴스

TGTX

TG Therapeutics (TGTX)

TG Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TGTX
일자시간출처헤드라인심볼기업
2024/05/0120:00GlobeNewswire Inc.TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:TGTXTG Therapeutics Inc
2024/05/0105:55GlobeNewswire Inc.TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business UpdateNASDAQ:TGTXTG Therapeutics Inc
2024/04/1820:30GlobeNewswire Inc.TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
2024/04/1820:00GlobeNewswire Inc.TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple SclerosisNASDAQ:TGTXTG Therapeutics Inc
2024/04/1520:30GlobeNewswire Inc.TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
2024/03/0821:30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
2024/03/0121:30GlobeNewswire Inc.TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual ForumNASDAQ:TGTXTG Therapeutics Inc
2024/03/0107:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TGTXTG Therapeutics Inc
2024/02/2821:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TGTXTG Therapeutics Inc
2024/02/2821:00GlobeNewswire Inc.TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:TGTXTG Therapeutics Inc
2024/02/2721:30GlobeNewswire Inc.TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)NASDAQ:TGTXTG Therapeutics Inc
2024/02/2621:00GlobeNewswire Inc.TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)NASDAQ:TGTXTG Therapeutics Inc
2024/02/2321:30GlobeNewswire Inc.TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business UpdateNASDAQ:TGTXTG Therapeutics Inc
2024/02/2021:30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual ForumNASDAQ:TGTXTG Therapeutics Inc
2024/02/1511:53Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:TGTXTG Therapeutics Inc
2024/02/1505:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TGTXTG Therapeutics Inc
2024/01/2706:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TGTXTG Therapeutics Inc
2024/01/1021:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TGTXTG Therapeutics Inc
2024/01/1021:00GlobeNewswire Inc.TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated MilestonesNASDAQ:TGTXTG Therapeutics Inc
2024/01/0923:20AllPennyStocks.comBiotech Massively Bid Up Before Opening BellNASDAQ:TGTXTG Therapeutics Inc
2024/01/0921:00GlobeNewswire Inc.TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune DiseasesNASDAQ:TGTXTG Therapeutics Inc
2024/01/0908:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TGTXTG Therapeutics Inc
2024/01/0908:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TGTXTG Therapeutics Inc
2024/01/0607:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TGTXTG Therapeutics Inc
2024/01/0601:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TGTXTG Therapeutics Inc
2024/01/0521:30GlobeNewswire Inc.TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TGTXTG Therapeutics Inc
2024/01/0406:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TGTXTG Therapeutics Inc
2023/11/2721:30GlobeNewswire Inc.TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:TGTXTG Therapeutics Inc
2023/11/0707:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TGTXTG Therapeutics Inc
2023/11/0320:30GlobeNewswire Inc.TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) ConferenceNASDAQ:TGTXTG Therapeutics Inc
 검색 관련기사 보기:NASDAQ:TGTX

최근 히스토리

NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
FX
USDGBP
US Dollar vs Sterling
NYSE
BAC
Bank of America
NYSE
MRK
Merck
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
COIN
ETHUSD
Ethereum
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유